Reports on insertional mutagenesis due to integration of gene therapy vectors into the host genome have raised concerns about the genetic manipulation of somatic cells. Previously, it was demonstrated that integrase C31 derived from a Streptomyces phage mediates site-specific integration into the host genome of mammalian cells in vitro and in vivo by recombining the attB recognition site in an episomal plasmid and one or more pseudoattP sites in the host chromosomes. In the present study we investigated whether cryptic C31 recognition sites in the host genome may result in chromosomal rearrangements. Of 69 independent integration events analyzed in human cells, 6 (8.7%) integrated into human chromosome 19 (19q13.31) and 10 (14.49%) integrated into human chromosome 12 (12q22). Most importantly, of all integration sites analyzed, 15% were found to contain an integrated transgene that was flanked by DNA sequences originating from two different chromosomes. To confirm chromosomal translocations we performed a polymerase chain reaction analysis of chromosomal DNA flanking the transgene and also performed limited studies to determine the genotype of single-cell clones. Although the mechanism responsible for chromosomal translocations needs to be further characterized, we speculate that cryptic C31 attachment sites flanking the transgene and cryptic C31 attachment sites in the host genome recombine with each other.
INTRODUCTION I
NTEGRATING VIRAL and non-viral-based vector systems for gene therapy have advantages and disadvantages. Integrating vector systems have the potential to result in persistent and life-long transgene expression. However, reports on insertional mutagenesis due to integration of gene therapy vectors into the host genome have raised concerns about the use of integrating vectors for gene therapy. It was demonstrated that human immunodeficiency virus type 1 (HIV-1) preferentially integrates into active genes, which significantly increased the risk of insertional mutagenesis (Schroder et al., 2002; Wu and Burgess, 2004) . Although only a small proportion of adeno-associated viral (AAV) vectors integrate, the vector genomes that do integrate have a preference for integration into active genes, but at present it remains to be shown whether this increases the risk of insertional mutagenesis (Nakai et al., 2003) . Besides the risk of insertional mutagenesis there is evidence that chromosomal changes at a molecular level (e.g., chromosomal deletions and insertions) occur at the target site of vector integration (Miller et al., 2002; Ehrhardt et al., 2005) . A previous report demonstrated that AAV vector integrations are associated with small deletions and rearrangements in the host chromosome (Miller et al., 2002) .
Integrase C31 is widely used in nonviral gene therapy approaches for somatic integration and, because of its potential to mediate site-specific integration, it represents an attractive tool for gene therapy. It was demonstrated that integrase C31 derived from a Streptomyces phage mediates site-selective integration into the host genome of mammalian cells in vitro and in vivo by recombining the attB recognition site in an episomal plasmid and one or more pseudo-attP sites (attPЈ) in the host chromosomes (Thyagarajan et al., 2001; Olivares et al., 2002) . C31 integrase has been used for gene therapy approaches and was tested in vitro and in vivo in mice (Olivares et al., 2002; Ortiz-Urda et al., 2002 Ehrhardt et al., 2005) . It was shown by Olivares et al. (2002) that site-specific genomic integration produces therapeutic factor IX levels in mice and that the hot spot mpsL1 in mouse liver is frequently targeted after C31-mediated integration. Other reports demonstrated genetic correction of inherited human skin disease (Ortiz-Urda et al., 2002) and in vivo correction of murine hereditary tyrosinemia type I (Held et al., 2005) . Moreover, C31 integrase was used in enhanced gene therapy approaches for muscular dystrophy (Bertoni et al., 2006) and for genomic integration of the common cytokine receptor ␥ chain in human T cell lines (Ishikawa et al., 2006) .
However, there was an accumulation of evidence that C31-mediated integration may have unwanted effects. A previous publication suggested integrase-related toxicity as demonstrated by transient abnormal hepatocytes, which were observed in mice that received a C31 integrase-encoding plasmid (Held et al., 2005) . One report from our laboratory demonstrated that C31-mediated integration results in frequent microdeletions and microinsertions at sites of insertion. More importantly, Liu et al. (2006) found that primary human fibroblasts show chromosomal abnormalities after transduction with C31 integrase. Furthermore, it was discussed by Chalberg et al. (2006) that aberrant chromosomal events may occur after C31-mediated integration.
A study that carefully analyzes molecular consequences for the host genome after C31-mediated integration for each independent integration event has not yet been reported. Previous studies showed that Cre-mediated integration into cryptic sites, which are present in the eukaryotic genome, resulted in chromosomal translocations at low frequencies (Thyagarajan et al., 2001) . In the present report we investigated whether cryptic C31 recognition sites would result in chromosomal rearrangements. We found that, after C31-mediated integration, 15% of all integrated transgenes were flanked by chromosomal DNA sequences originating from different chromosomes. Careful analyses of these chromosomal DNA sequences revealed that hot spots of integration may be involved in the formation of chromosomal rearrangements.
MATERIALS AND METHODS

DNA constructs
Plasmid P11 was described previously (Ehrhardt et al., 2005) . Plasmid P7 was generated by replacing the low-copy bacterial origin of replication p15A with the high-copy origin of replication ColE1, using the following polymerase chain reaction (PCR) primers: pUCori sense (5Ј-CGA TTT CGA AGA GCA AAA GGC CAG CA-3Ј) and pUCori antisense (5Ј-CGA TGA AGT GCT TCC TGC GCG TAA TC-3Ј). The C31 integrase expression plasmid pCMV-INT, in which the C31 cDNA is driven by the cytomegalovirus (CMV) promoter, has been used in previous studies (Olivares et al., 2002; Ehrhardt et al., 2005) . The plasmid pCMV-mINT, expressing an inactive version of the integrase C31, was described in earlier studies (Olivares et al., 2002; Ehrhardt et al., 2005) . This mutated version of the phage integrase C31, which contains an S12F mutation, has been described (Thorpe and Smith, 1998) .
Cell culture
The human embryonic cell line 293 was maintained in Dulbecco's modified Eagle's medium (DMEM; Mediatech, Herndon, VA) supplemented with L-glutamine (GIBCO-BRL/Invitrogen, Carlsbad, CA), penicillin-streptomycin (GIBCO-BRL/ Invitrogen), and fetal bovine serum (10%). The human hepatoma cell line Huh7 and the mouse hepatoma cell line Hep1A were maintained in DMEM (Mediatech) supplemented with Lglutamine (GIBCO-BRL/Invitrogen), penicillin-streptomycin (GIBCO-BRL/Invitrogen), nonessential amino acids (GIBCO-BRL/Invitrogen), and fetal bovine serum (10%). The human colon carcinoma cell line HCT116 was maintained in McCoy's 5A medium (modified) with 1.5 mM L-glutamine adjusted to contain sodium bicarbonate at 2.2 g/liter, and fetal bovine serum (10%).
Colony-forming assay
To determine the integration efficiencies of circular substrates for C31-mediated integration a colony-forming assay was performed. Cells were seeded in 6-cm dishes and, at 50 to 80% confluency, were transfected with the plasmid DNA, using SuperFect (GIBCO-BRL/Invitrogen). The circular C31 substrates P7 and P11 for C31-mediated integration were either transfected into cells with the active version of the C31 integrase (C31) or the mutated C31 integrase (m-C31). As a negative control we cotransfected "stuffer" DNA, which was derived from the plasmid pBluescript (Stratagene, La Jolla, CA). The substrates P7 and P11 contained the C31 recognition site attB and a neomycin expression cassette for expression in mammalian cells, which allows for cell growth in selective medium containing G418. For transfection 2 g of the substrate and the C31-or m-C31-encoding plasmid were cotransfected. An additional control group received 2 g of the circular substrate and "stuffer" DNA. Forty-eight hours after transfection cells were split into 10-cm dishes at two different densities (3.8 ϫ 10 4 and 3.8 ϫ 10 5 cells per 10-cm dish). After 14 days of G418 (500 g/ml) selection colonies were stained with methylene blue and counted. Single-cell clones from all
FIG. 1.
C31-mediated integration efficiencies in various cell lines in vitro and strategy to determine and characterize sites of insertion. (a) DNA constructs used in this study and integration efficiencies after C31-mediated integration in Huh7, Hep1A, 293, and HCT116 cells. The C31-encoding plasmid (INT) was cotransfected with plasmid P7 or P11 into Huh7, Hep1A, 293, and HCT116 cells. P7 is based on the plasmid for integration site rescue P11, but contains the high copy origin of replication (oriP) instead of the low copy origin of replication (p15A). P7 and P11 contain the neomycin resistance gene, the simian virus 40 (SV40) promoter for expression in mammalian cells, the Tn5 promoter for expression in bacteria, and the C31 attachment site attB. Control groups received the mutated (inactive) version of C31-encoding plasmid (m-INT). After 14 days of selection single-cell colonies were stained with methylene blue and counted. (b) The plasmid rescue protocol. Single colonies were isolated, using cloning cylinders followed by five serial passaging steps in selective medium. Genomic DNA was isolated; digested with SpeI, NheI, and XbaI; ligated; and transformed. Single colonies were analyzed and sequenced. The agarose gel shows the diagnostic digest of various rescued plasmids from cell clones and, for comparison, the original plasmid P7, which was used for transfection studies in mammalian cells. A PstI digest of all rescued plasmids was performed, which releases a 1.6-kb band from the integrated transgene.
four cell lines were isolated by a ring-cloning strategy and amplified. Cells were kept under G418 (500 g/ml) selection.
Isolation of genomic DNA from cells
Cells were trypsinized and the cell pellet was resuspended in 200 l of Dulbecco's phosphate-buffered saline (DPBS) buffer and digested overnight with proteinase K. This step was followed by phenol and chloroform extraction and subsequent ethanol precipitation.
Analyses of integration events in single-cell clones
Seven micrograms of genomic DNA from cell clones was digested with the restriction enzymes SpeI, XbaI, and NheI, sites which are not present in the integrated transgene expression cassette. After religation of the cut DNA in a total volume of 100 l and ethanol precipitation to reduce the total volume to 20 l, competent DH10B cells (GIBCO-BRL/Invitrogen) were electroporated and single colonies were analyzed by restriction enzyme pattern. For sequencing, the primers attB-R380 (5Ј-cgtgaccaccgcgcccagcggttt-3Ј) and attB-F (5Ј-taccgtcgacgatgtaggtcacggtc-3Ј) were used. Rescued plasmids were analyzed by restriction enzyme digest.
Detection of chromosomal translocations by PCR
A PCR was designed in which the PCR product spans the hybrid sites attR and attL, consisting of part of the attB recognition site in the substrate for C31-mediated integration and the pseudo-attP site in the host genome, respectively. The primers attB-F (5Ј-taccgtcgacgatgtaggtcacggtc-3Ј) and attB-R380 (5Ј-cgtgaccaccgcgcccagcggttt-3Ј) were used for binding in the attB arm of the integrated vector DNA. For detection of DNA sequences flanking the integrated vector DNA by PCR in genomic DNA of cell clone H1A7, we used the primers 1A7-255-forw (5Ј-gcatagagaggagactgaggctcc-3Ј) and 1A7-EHRHARDT ET AL. 1080
FIG. 2.
Summary of sites of insertion in the mouse and human genomes and sequence comparisons between the wild-type attP site and the two reported dominant hot spots in this study found in human-derived cells. (a) Summary of hot spots found more than once in the human and mouse genomes, determined from all analyzed sites of insertion. Eighty-one cell clones were picked after 14 days of G418 selection and amplified. (b) Overall distribution of sites of insertion in human cells. Enlarged are the two hot spots in the human genome on chromosome 19 (Chr 19q13.31) and chromosome 12 (12q22). (c) Distribution of sites of insertion in the mouse genome. Enlarged is the hot spot in the mouse genome on chromosome 2. (d) Sequence comparisons between the wild-type attP site and the two reported dominant hot spots. Shown are the DNA sequences, including the reverse complementary strand of the wild-type attP site (Wt-attP) and the two hot spots on chromosome 19 (Chr 19q13.31) and on chromosome 12 (Chr 12q22). The core sequence is shown in green for Wt-attP and the potential core sequences for the hot spots are depicted in blue. Palindromic sequences for Wt-attP are boldface and underlined and sequence similarities between Wt-attP and the hot spots are marked in red.
324-rev (5Ј-cgtacgtgtgcgtgtgtctttata-3Ј). To detect DNA sequences flanking the integrated vector in genomic DNA of cell clone 1C15, we used the primers 1C15-327-forw (5Ј-gaatgtgctgtgcttccaggcctc-3Ј) and 1C15-176-rev (5Ј-gccagggtagagtgcggagcccca-3Ј). For cell clone 1B5 we used the primers 1C15-327-forw (5Ј-gaatgtgctgtgcttccaggcctc-3Ј) and 1B5-104-rev (5Ј-ctgccgtcaggagggcctttagaa-3Ј). For cell clone 1C5 we performed a PCR with primers 1C5-230-forw (5Ј-tacacacgaagtccttgcccatgc-3Ј) and 1C15-176-rev (5Ј-gccagggtagagtgcggagcccca-3Ј). 
HIGH-FREQUENCY CHROMOSOMAL REARRANGEMENTS BY
Detection of potential stable integration of the C31-encoding DNA by PCR
To test potential integration of the integrase-encoding vector into the host genome, the genomic DNA of four HCT116 cell clones and two control cell clones (2B6 and 2C7) was analyzed by PCR with C31-specific primers (Int 5Ј 1383, 5Ј-ggcagcggtaagagtccttgatcg; and Int 3Ј 1918, 5Ј-cgagttcgagcccgacgtaatccg) .
Karyotype analysis
After mitotic arrest, monolayer cell cultures in log-phase growth were harvested by standard cytogenetic methods of trypsin dispersal, hypotonic shock, and fixation (Barch and Knutsen, 1997) . Mitotic cell slide preparations were analyzed by the GTW (G-banding with. trypsin and Wright's stain) banding method (Seabright, 1971) .
RESULTS
The goal of this study was to analyze the consequences of integrase C31-mediated integration events in various cell lines. To do this, we first characterized the chromosomal integration sites after C31-mediated integration from extrachromosomal DNA plasmid substrates. The analyses were performed in two liver-derived cell lines, Huh7 (human hepatoma cell line) and Hep1A (mouse hepatoma cell line); the human embryonic kidney cell line 293; and the human colon carcinoma-derived cell line HCT116. DNA constructs used to determine integration efficiencies are depicted in Fig. 1a (top) . To determine integration efficiencies in all four cell lines, we performed a colony-forming assay, which allows for selection of cells in which an integration event has occurred. The number of cell clones selected via the colony-forming assay from all four cell lines revealed 6.0-, 17.2-, 4.5-, and 7-fold increases in the number of colonies in Huh7, Hep1A, 293, and HCT116 cells, respectively, compared with the mutant integrase control group (Fig. 1a, bottom) .
We amplified 22, 8, 31, and 18 cell colonies from Huh7, 293, HCT116, and Hep1A cells, respectively. Thus, 79 single-cell clones from all four cell lines were amplified and sites of insertion were characterized on the basis of an established plasmid rescue protocol that allows identification of both chromosomal DNA sequences flanking the integrated transgene. The strategy to identify sites of insertion is shown schematically in Fig. 1b . Fourteen of these 79 cell clones revealed more than one site of insertion, which accounts for a total of 93 analyzed sites of insertion. Of 69 independent integration events analyzed in human Huh7, 293, and HCT116 cells, 6 (8.70%) integrated into human chromosome 19 (19q13.31) and 10 (14.49%) integrated into human chromosome 12 (12q22) (Fig. 2a) . In HCT116 cells, all 10 integration sites found on chromosome 12 were located in an intergenic region, suggesting that the ob-
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FIG. 5.
Description of chromosomal rearrangements after C31-mediated integration in human and mouse cells. Sites of insertion were determined by an established plasmid rescue protocol. The original chromosomal sequences before transgene integration are shown above the two merged chromosomal sites flanking the integrated vector sequence. Schematically shown are the integrated vector sequences flanked by the attR and attL sites, which are hybrid sites of the C31 recognition site attB contained in the substrate for C31-mediated integration and the pseudo-attP site in the chromosomal DNA. Chromosomal DNA is marked in either green or blue, the attB-derived sequences are shown in red and black, and insertions are marked with boldface black letters. The TTG core at which C31-mediated integration occurs is underlined. Deletions in the attB arm are hyphenated.
served hot spots of integration may be cell line dependent. Four of 24 integration sites in the mouse hepatoma cell line Hep1A were found on a previously described hot spot on chromosome 2 (band H3) in mouse liver (Fig. 2a) . The overall distribution of all integration sites in human-and mouse-derived cells is schematically shown in Fig. 2b (human cells) and Fig. 2c (mouse cells). For further information, all identified sites of insertion are listed and described in detail in Figs. 8-11 (see below). A detailed description of the hot spots in human cells at the nucleotide level and sequence homologies between two hot spots on chromosome 19 (Chr 19q13.31) and on chromosome 12 (Chr 12q22) and the wild-type attP site are shown in Fig.  2d . The nucleotide range of all three hot spots in which transgene integration occurred on human chromosomes 12 and 19 and mouse chromosome 2 are schematically shown in Fig. 3a-c . Further analyses of sites of insertion revealed frequent smaller deletions of up to 37 bp in chromosomal target sites but also seven larger deletions between 176 bp and 720,199 bp in size (Fig. 4a) . As previously shown, we found microdeletions of up to 29 bp in the phage integrase attachment site attB in Huh7, HCT116, 293, and Hep1A cells (data not shown). We also observed frequent insertions at the chromosomal target sites of up to 426 bp, but most of the insertions were Ͻ4 bp (Fig. 4a) . The origin of these inserted DNA sequences remains to be determined. As depicted in Fig. 4b , detailed analysis of 93 sites revealed that 71.8% of all chromosomal sites that were targeted by C31 were within genes, confirming an integration bias into gene regions. More importantly, there was strong evidence that chromosomal rearrangements due to C31-mediated vector integration might have occurred. In total, 14 of 93 (15.0%) of all integration sites analyzed were found to contain an integrated transgene that was flanked by DNA sequences originating from two different chromosomes (Fig. 4c) . This observation was made in all four cell lines and strongly suggested EHRHARDT ET AL. 1084   FIG. 6 . Karyotyping analysis of the cell clone H1A7 derived from HCT116 cells. The human colon carcinoma cell line HCT116 was used because the karyotype of this cell type is well characterized (Mohr and Illmer, 2005) . Shown is the G-banding pattern of (a) the parental cell line HCT116 and (b) the cell clone H1A7 for which our plasmid rescue results strongly indicated that a translocation must have occurred. Solid arrowheads show the established and published translocations in the cell line HCT116 and open arrowheads mark the changed genotype in the cell clone H1A7. The translocation found by the plasmid rescue method as well is circled. HCT116 cells, in contrast to the other cell lines used in the present study, maintain a relatively stable genotype (Schmidt et al., 2000) . (c) Summary of metaphase chromosomes in the parental cell line HCT116 and the cell clone H1A7. 
C31-encoding
plasmid pCSI (Schroder et al., 2002; Wu and Burgess, 2004) was used.
FIG. 8A.
Rescued sites of insertion from the colon carcinoma cell line HCT116.
FIG. 8B.
FIG. 9A.
Rescued sites of insertion from the human hepatoma cell line Huh7.
FIG. 9B.
that chromosomal rearrangements occurred. This assumption is further supported by the fact that the same experimental approach was used with our Sleeping Beauty transposon vector studies, and no integration sites flanked by sequences from two chromosomes were observed in more than 1000 analyzed events (Yant et al., 2005) and with AAV vectors, less than 0.25% (1 of 400) of all sites of insertions occurred between two chromosomes (Nakai et al., 2005) . Figure 5 shows in detail the rescued integration sites, which contained two different chromosomes flanking the integrated vector sequence. Interestingly, in 4 of the 14 detected translocations, one chromosomal site was derived from one of the hot spots described above.
To confirm that chromosomal translocations did occur and were caused by C31-mediated integration, we performed karyotypes on single-cell clones in HCT116 cells, a cell line for which the chromosomal content is relatively stable and well characterized (Mohr and Illmer, 2005) . In sharp contrast to wild-type HCT116 cells, the karyotype for cell clone H1A7 revealed that starting on chromosome 22 band q13 the origin of the DNA sequences on this chromosomal arm could not be identified, which was consistent with the plasmid rescue data ( Fig.  6a and b) . All 24 metaphases examined in cell clone H1A7 had the same chromosomal abnormality on chromosome 22 band q13, suggesting that the chromosomal rearrangement occurred early in the process of clonal expansion of cells containing this specific integration (Fig. 6c) . The karyotypes of two additional cell clones were inconclusive, but the karyotype of three control cell clones did not show significant differences compared with the parental HCT116 cell line. However, we were able to confirm translocations in cell clones derived from HCT116 cells (H1A7, H1C15, H1C5, and H1B5) by a PCR strategy that amplifies flanking sequences of the integrated transgene (Fig. 7) , further supporting that the translocation was a bona fide event. Although the mechanism responsible for chromosomal translocations needs to be further characterized, we speculate that cryptic C31 attachment sites flanking the transgene and cryptic C31 attachment sites in the host genome recombine with each other. We speculate that it may also be possible that recombination occurs among cryptic attachment DNA sequences present in the host genome.
Figures 8-11 provide detailed information on all identified integration sites in human-and mouse-derived cells.
DISCUSSION
The present study carefully analyzes consequences for the target cell at a molecular level after C31-mediated integration. In this study we found that the bacteriophage-derived integrase C31 induced chromosomal rearrangements in the mammalian host genome with a frequency of up to 15% as demonstrated by integration site analysis, PCR analyses of translocations, and limited karyotyping studies. Molecular analyses revealed that integrated transgenes are flanked by two different chromosomes and that in 4 of 14 translocation events translocations occurred between hot spots of C31-mediated integration. At present, it is unclear whether translocations also occur in quiescent cells in vivo. Immortalized and rapidly dividing cells in vitro are genetically more unstable compared with quiescent cells. Thus, chromosome breaks may occur more often in immortalized cells compared with quiescent cells. A study by Liu et al. (2006) showed that chromosomal translocations can be detected in human primary fibroblasts after transfection of a C31-encoding plasmid and a substrate with the attB recognition site. The studies to date used selection to isolate cells with integration events. Additional studies performed in the absence of selection in quiescent cells in vivo are needed. In addition to chromosomal translocations, we frequently found microdeletions and insertions at the site of insertion. This finding is in concordance with our previous studies (Ehrhardt et al., 2005) . However, we also found seven larger deletions between 176 and 720,199 bp and larger insertions at the chromosomal target sites of up to 426 bp.
One important finding of the present study was that the integration specificity of C31 may be cell line dependent. The predominant hot spot of integration in HCT116 derived from a colon carcinoma was found on chromosome 12 (Chr 12q22) and the hot spot of integration in human cell lines Huh7 and 293 was identified on chromosome 19 (Chr 19q13.31) . A hot spot of integration on chromosome 19 was also identified by Chalberg et al., but the hot spot on chromosome 12 was specific for HCT116 cells, indicating that this hot spot is specific for this cell line.
We performed a detailed characterization of sites of insertion and found that 71.76% of all sites of insertion were in genes. This is in contrast to the study performed by Chalberg et al. (2006) , who found that only 38.7% of all sites of insertion were in genes. One reason for these discrepancies may be the vector that was used as a substrate for C31-mediated integration and subsequent identification of sites of insertion. The size of the plasmid may play a role, as may the enzymes used to cut genomic DNA when performing the plasmid rescue protocol. A smaller plasmid may be less biased toward the smaller chromosomal DNA fragments that are rescued when performing the plasmid rescue protocol.
At present, we can only speculate about the mechanism involved in the induction of chromosomal rearrangements by bacteriophage integrase C31. After integration of the transgene, the integrated foreign DNA is flanked by attR and attL, which are hybrid sites consisting of part of the pseudo-attP site in the host genome and part of the C31 recognition site attB contained in the substrate. We speculate that after integration of the transgene, integrase C31 may recombine either attR or attL with other attPЈ sites present on other chromosomes. It is estimated that up to 1000 attPЈ sites are present in the mammalian genome, and in addition it is known that for integration to occur, the required sequence homology between the wild-type attP site and pseudo-attP sites is less than 30%. It remains to be shown whether bacteriophage integrase C31 is capable of recombining pseudo-attP sites on different chromosomes even without any substrate being present.
In summary, this feature of C31 will introduce novel ways to genetically modify mammalian cells and to study the fate of cells with chromosomal translocations. Induction of specific chromosomal rearrangements is in general introduced, in a labor-intensive way, by the well-established Cre recombinaseloxP system (Schmidt et al., 2000; Yu and Bradley, 2001) . The findings of the present study may pave the way for induction
